CMS Finalizes 2025 Pricing for Cardiovascular Disease Tests
Cardio Diagnostics Holdings announced that the CMS finalized gapfill pricing determinations for its AI-powered cardiovascular disease tests.Â
Category: Cardiovascular
Cardiovascular
Latest
Cardiovascular
Latest
Increased Testing for Heart Disease Indicator Needed
A new review finds that 20% of the global population carries a genetic risk for cardiovascular diseases due to high levels of lipoprotein(a).
Cardiovascular
Latest
Roche’s Lipoprotein Blood Test Gets Breakthrough Device Designation
Roche announced that its Tina-quant lipoprotein Lp(a) RxDx assay received Breakthrough Device Designation from the FDA.
Biomarkers to Predict Cardiovascular Risks in Type 2 Diabetes Patients Identified
Researchers extracted data on 321 biomarkers and found 13 were significantly associated with cardiovascular risk in type 2 diabetes patients.
Read More
Two Common Biomarkers Predict Heart Risk in Asymptomatic Childhood Cancer Survivors
The biomarkers may help more quickly predict cardiomyopathy in high-risk, asymptomatic childhood cancer survivors.Â
Read More
Two-Step Screening Strategy Could Reduce Diabetic Heart Failure
A two-step screening protocol can effectively identify which patients with Type 2 diabetes need medication to prevent heart failure.
Read More
New Test Aids Emergency Diagnosis of Heart Conditions
Patients with a heart muscle injury caused by other heart conditions benefitted the most from the new troponin measurement method.
Read More
Bio-Rad Expands Instrument Compatibility for Cardiac Advance Control
Bio-Rad Laboratories expanded the compatibility of its newest cardiac control, Cardiac Advance, to now include Beckman-Coulter instruments. Â
Read More
Earlier Detection of Pediatric Cardiometabolic Risk Factors through Next-Gen Biomarkers
Next-gen cardiometabolic biomarkers will aid earlier detection of risk factors for obesity, diabetes, and heart disease in children.
Read More
Mindray Expands Cardiac Biomarker Portfolio with New Assays
Mindray introduced new cardiac biomarkers aimed at diversifying its portfolio for cardiovascular disease diagnosis and management.
Read More
New Blood Test Measures Levels of Critical Omega-3 Fatty Acids
Researchers discovered a way to track levels of omega-3 fatty acids in the bloodstream to gain information critical to cardiovascular health.
Read More
American College of Cardiology to Increase Cholesterol Screenings Through New Program
The national program will reach about 30,000 primary care providers and cardiologists, and will assess the state of LDL screenings.
Read More
Cardio Diagnostics Holdings Collaborates on Cardiovascular Health Initiative for Truckers
Cardio Diagnostics is collaborating with Truckers Health Network, an organization providing health and wellness options to truckers.
Read More
How Routine Genetic Testing Could Benefit Patients with an Advanced Heart Disease
A new study demonstrated the benefits of routine genetic testing for patients with advanced disease from dilated cardiomyopathy (DCM).
Read More
Proactive Diagnostic Strategy Identifies Cardiovascular Disease in the Community
Active screening of patients with type 2 diabetes or COPD more than doubles new diagnoses of cardiovascular disease compared with usual care.
Read More
Home Blood Test for Cardiometabolic Health Publicly Available
CardioMetaboliQ, an at-home blood test that empowers users to support their cardiovascular and metabolic health, is available to consumers.Â
Read More
How a Plasma Sample’s Protein Score Can Predict Cardiovascular Disease
Researchers recently employed AI to develop a protein score to predict major atherosclerotic cardiovascular disease events (ASCVD).
Read More
This Blood Test May Predict Heart, Kidney Risk for Those With Diabetes
A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease.
Read More